In a zebrafish model with FOCAD deficiency, liver injury was accompanied by increased CCL2 expression, suggesting that targeting the CCL2/CCR2 axis could be a new approach for treating pediatric liver cirrhosis (56). Here, CCL2 is linked to cirrhosis of liver.